White House urges greater use of Paxlovid as supply increases
By
Alicia Lasek (f3)
Apr 28, 2022
Health officials are encouraging physicians to more frequently consider prescribing the oral antiviral now that it is no longer in short supply.
New approach supports comprehensive advance care planning in nursing homes
By
Alicia Lasek (f3)
Apr 28, 2022
A comprehensive advance care planning model was highly rated by residents or their proxies, and linked to decreased use of antimicrobials, investigators say.
Clinical briefs for Thursday, April 28
By
Alicia Lasek (f3)
Apr 28, 2022
Cleveland Clinic: Calcium supplements linked to earlier death in seniors with heart disease … In new video, AHCA’s chief doc urges nursing home staff to get vaccinated … Cholesterol drug lowers risk...
‘A long time coming’: LTC infection preventionists get new certification option
By
Alicia Lasek (f3)
Apr 27, 2022
A new opportunity to receive industry-specific IPC board certification is a much-needed chance for LTC workers to build and show their niche expertise, experts say.
More than half of Americans now have antibodies against COVID-19, CDC reports
By
Alicia Lasek (f3)
Apr 27, 2022
Nearly 58% of Americans had antibodies to SARS-CoV-2 by February 2022, meaning that a majority of the country’s population has been exposed to the virus, new CDC data reveals.
Clinical briefs for Wednesday, April 27
By
Alicia Lasek (f3)
Apr 27, 2022
OSHA’s proposed COVID-19 healthcare rule too prescriptive, LTC leaders say … Stroke patients with Afib at increased risk of recurrent stroke … Alzheimer’s and daytime napping linked in new...
CDC: Turn to Paxlovid to treat COVID-19, not steroids or antibiotics
By
Alicia Lasek (f3)
Apr 26, 2022
The agency is urging clinicians to consider the now readily available, recommended therapies such as Paxlovid as first-line COVID-19 treatments.
No adverse booster shot events found in LTC residents; vaccines potent against omicron, studies reveal
By
Alicia Lasek (f3)
Apr 26, 2022
A study across 239 Genesis nursing homes has found no evidence of adverse reactions to COVID-19 booster shots among residents. The news arrives alongside new studies showing booster efficacy against the...
Frail heart failure patients improve with common diabetes drug, trial finds
By
Alicia Lasek (f3)
Apr 26, 2022
The SGLT2 inhibitor Farxiga substantially reduced risk for worsening heart failure events and death in frail patients, a new analysis finds. The more frail the patient, the more benefits seen.
Clinical briefs for Tuesday, April 26
By
Alicia Lasek (f3)
Apr 26, 2022
iCare capitalizes on skilled nursing’s behavioral health opportunities … New trial data confirms that overactive bladder drug reduces urgency … Eli Lilly marketing campaign sets stage for Alzheimer’s...